ବାୱେଲ୍ (କୋଲୋରେକ୍ଟାଲ୍) କ୍ୟାନ୍ସର
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III Study to Evaluate the Efficacy and Safety of Nuvastatic® 300mg Capsule in Reducing Cancer-Tumor in Patients With Metastatic Colorectal Cancer Receiving Standard Chemotherapy.
କେଉଁଠିକୁ ଯିବେ
ଏହି trial ପାଇଁ ଭାରତରେ ୬ଟି hospital ରୋଗୀଙ୍କୁ ନେଉଛନ୍ତି.
ରେଜିଷ୍ଟ୍ରି ସାରାଂଶ (ଟେକ୍ନିକାଲ୍)
The goal of this clinical trial is to evaluate whether Nuvastatic 300 capsule can reduce cancer-related fatigue in adult patients with colon cancer undergoing first-line chemotherapy. The main questions it aims to answer are: Does Nuvastatic 300 capsule significantly reduce cancer-related fatigue compared to placebo? Is Nuvastatic 300 capsule safe and well tolerated in this patient population? Researchers will compare Nuvastatic 300 capsule vs placebo to see if Nuvastatic 300 capsule improves fatigue scores and maintains an acceptable safety profile. Participants will: Receive Nuvastatic …
ପ୍ରାୟୋଜକ: ନେଚରସିଉଟିକାଲ୍ସ ଏସଡିଏନ ବିଏଚଡି
ClinicalTrials.gov ରେ NCT07669454
ରେଜିଷ୍ଟ୍ରିରେ ଶେଷ ଅପଡେଟ୍ 25 ଜୁନ 2026 · ଆମ ଦ୍ୱାରା 20 ଅକ୍ଟୋବର 2026 ରେ ପଢାଯାଇଛି